Dr. Lopez-Ramirez
Dr. Miguel Alejandro Lopez-Ramirez is focused on the development of non-invasive drug treatments to treat cardiovascular and neurological diseases.
Dr. Lopez-Ramirez received degrees in Pharmaceutical Science and Molecular and Cellular Neurobiology. He is trained as a Neurovascular Biologist researching the molecular and genetic mechanisms that provide an understanding of the pathological and physiological roles of genetic abnormalities. He received postdoctoral research training studying vascular network formation in living organisms at Yale University. He then moved to UCSD to study the roles of genes involved in cerebral cavernous malformations and their implications in cardiovascular biology. Dr. Lopez-Ramirez is now an Assistant Professor in the School of Medicine at UC San Diego.
About the Lab
Our lab utilizes genetics, cell biology, and bioinformatic tools to understand cerebral cavernous malformations (CCMs) and neuroinflammation, which can lead to debilitating strokes and currently lack pharmacological treatments. Our research suggests that mild angiogenesis inhibitors like thrombospondin1 derivatives and endothelial microRNAs could offer promising therapeutic avenues for these conditions, aiming to develop non-invasive and effective treatments for cardiovascular and neurological diseases.
Read More About the Lab